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AbsTrACT
Introduction Evidence-to-decision (EtD) frameworks 
intend to ensure that all criteria of relevance to a health 
decision are systematically considered. This paper, part 
of a series commissioned by the WHO, reports on the 
development of an EtD framework that is rooted in WHO 
norms and values, reflective of the changing global health 
landscape, and suitable for a range of interventions 
and complexity features. We also sought to assess the 
value of this framework to decision-makers at global 
and national levels, and to facilitate uptake through 
suggestions on how to prioritise criteria and methods to 
collect evidence.
Methods In an iterative, principles-based approach, we 
developed the framework structure from WHO norms 
and values. Preliminary criteria were derived from key 
documents and supplemented with comprehensive 
subcriteria obtained through an overview of systematic 
reviews of criteria employed in health decision-making. We 
assessed to what extent the framework can accommodate 
features of complexity, and conducted key informant 
interviews among WHO guideline developers. Suggestions 
on methods were drawn from the literature and expert 
consultation.
results The new WHO-INTEGRATE (INTEGRATe Evidence) 
framework comprises six substantive criteria—balance 
of health benefits and harms, human rights and 
sociocultural acceptability, health equity, equality and 
non-discrimination, societal implications, financial and 
economic considerations, and feasibility and health 
system considerations—and the meta-criterion quality of 
evidence. It is intended to facilitate a structured process 
of reflection and discussion in a problem-specific and 
context-specific manner from the start of a guideline 
development or other health decision-making process. For 
each criterion, the framework offers a definition, subcriteria 
and example questions; it also suggests relevant primary 
research and evidence synthesis methods and approaches 
to assessing quality of evidence.
Conclusion The framework is deliberately labelled version 
1.0. We expect further modifications based on focus group 
discussions in four countries, example applications and 
input across concerned disciplines.
bACkground
Health decision-making at local, national, 
regional and global levels is complex,1–3 
and can be influenced by a broad range of 
factors.4–9 Their importance varies depending 
on the type of health decision and the deci-
sion-making context,10 11 where context can 
relate to the institutional context (eg, Ministry 
of Health vs municipality), as well as the 
broader physical and social context, including 
epidemiological, geographical, sociocultural, 
key questions
What is already known?
 ► Evidence-to-decision (EtD) frameworks help to en-
sure that all criteria of relevance in a given guideline 
development or other health decision-making pro-
cess are considered in a systematic way.
What are the new findings?
 ► The WHO-INTEGRATE (INTEGRATe Evidence) frame-
work is a new EtD framework that is rooted in the 
norms and values of the WHO, which are agreed on 
by all WHO Member States.
 ► The framework was developed to be applicable to 
all health interventions, although it is particularly 
well suited for decisions about population-level and 
system-level interventions at the global as well as 
national levels.
 ► The WHO-INTEGRATE framework offers structured 
definitions for each of the six substantive criteria as 
well as the meta-criterion quality of evidence; exam-
ple questions and suggested methods are provided 
to facilitate uptake.
What do the new findings imply?
 ► As part of a more holistic approach, the framework 
is devised as a tool to facilitate structured reflec-
tion and discussion from the beginning to the com-
pletion of a guideline development or other health 
decision-making process; this entails prioritisation 
among criteria and subcriteria to ensure appropriate 
evidence collection and appraisal.
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political and other aspects.12 Health decision or 
evidence-to-decision (EtD) frameworks are intended to 
ensure that all important factors—in the form of decision 
criteria—are considered in a systematic and transparent 
way.13–19 They provide a structured approach for guide-
line panels or other decision-making bodies to consider 
the available evidence and to make informed judgements 
about the advantages and drawbacks of a given health 
decision; this approach can comprise substantive criteria 
as well as procedural aspects. Health decision frame-
works have been applied in a variety of decision-making 
contexts.20 21 
Guidelines by the WHO provide recommendations 
for clinical practice, public health and health system 
strengthening, and are intended to support health deci-
sion-makers in prioritising among or selecting suitable 
clinical, public health or health system interventions. 
When formulating recommendations, WHO generally 
uses an EtD framework which encompasses eight criteria: 
quality of evidence (in relation to intervention benefits and 
harms), values and preferences (in relation to outcomes), 
balance of benefits and harms, resource implications, priority 
of the problem, equity and human rights, acceptability, and 
feasibility (table 10.1 of the WHO Handbook for Guideline 
Development).22
Chapter 10 in the WHO Handbook for Guideline Devel-
opment  22 was written by one of the lead authors of the 
Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) and the GRADE EtD 
frameworks. The criteria in the current WHO EtD 
framework represent an advanced but—given their 
publication in 2014—not the final version of the GRADE 
EtD framework, which offers different versions for clin-
ical recommendations from an individual or population 
perspective, coverage decisions, health system/public 
health decisions and recommendations about tests.13 23 
In a recent systematic review of frameworks concerned 
with generic health decision-making and resource alloca-
tion processes, health technology assessments, as well as 
very specific health decisions, the GRADE EtD framework 
emerged as the best fit-for-purpose framework (Stratil 
et al, forthcoming). In particular, this framework can 
be applied across diverse types of health decisions and 
was developed following an iterative and multipronged 
process, combining a literature review, brainstorming 
and feedback from stakeholders,24 with application of the 
framework to examples and user-testing.20 25
However, a number of weaknesses were identified with 
the GRADE EtD frameworks (Stratil et al, forthcoming). 
First, the framework was developed using a pragmatic 
approach and lacks an explicit theoretical or conceptual 
basis. This makes it difficult to assess objectively whether 
the set of criteria is complete and organised in a mean-
ingful way.
Second, while the frameworks are largely congruent 
with WHO norms and values, they do not sufficiently 
consider the central role of the social and economic 
determinants of health26 and the implications of health 
sector or intersectoral interventions for society as a 
whole. This is particularly important given the significant 
shifts in the global health landscape and the objectives 
and values manifest in the Sustainable Development 
Goals (SDGs),27 which are likely to shape health deci-
sion-making in the future.
A third concern is whether the decision criteria in the 
GRADE EtD framework are sufficiently complete and 
useful for decisions about complex interventions and/
or the complex systems in which these are implemented, 
especially interventions aiming to bring about system-
level changes.28
Fourth, the frameworks were originally developed 
in consultation with healthcare decision-makers in 
Europe, Canada and Africa, the majority of whom 
were physicians with significant clinical experience and 
research training.24 As a result, the frameworks may not 
be entirely suitable to broader public health and health 
system decision-making contexts, particularly in low-in-
come and middle-income countries of Asia and Latin 
America.
A final and important concern relates to consistency 
in the application of the GRADE EtD frameworks within 
the WHO guideline development processes. While there 
are exemplar guidelines, where the WHO EtD frame-
work has been employed as intended,29 30 many WHO 
guideline development groups focus extensively on 
the criterion balance of benefits and harms and apply the 
remaining criteria as a check box exercise rather than as 
a process that structures the development of guidelines 
from the start: from scoping a guideline and prioritising 
questions, to collecting, synthesising and appraising 
evidence, to formulating recommendations (SL Norris, 
2017, personal communication). While there are many 
potential reasons for this, the current content and struc-
ture of the GRADE EtD framework may result in super-
ficial use rather than indepth collection and assessment 
of evidence for the different criteria. In particular, guid-
ance on how to frame questions for and collect evidence 
towards criteria beyond balance of health benefits and 
harms appears to be missing.
This paper, one of a series exploring the implica-
tions of complexity in systematic reviews and guideline 
development, reports on the development of a new EtD 
framework that is rooted in WHO norms and values 
and suitable for a broad range of health interventions, 
including complex interventions and interventions deliv-
ered in complex systems.
The paper addresses the following three objectives:
1. Develop an EtD framework that (a) is firmly rooted in 
WHO norms and values and reflective of the changing 
global health landscape, and (b) encompasses a com-
prehensive set of criteria suitable for clinical practice, 
public health and health system interventions.
2. Explore the value of this framework in relation to (a) 
complexity in individual-level as well as population-lev-
el and system-level interventions, (b) the views of de-
velopers of the WHO guidelines (global level), and 
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(c) the views of users of the WHO guidelines (national 
level).
3. Facilitate uptake of the framework by emphasising the 
need for structured, evidence-based reflection and sug-
gesting methods to populate the criteria with evidence 
in the context of decision-making under uncertainty.
The EtD framework developed out of this process 
is referred to as the WHO-INTEGRATE (INTEGRATe 
Evidence) framework version 1.0. It is proposed for 
use in the WHO guideline development as well as in 
other guideline development or health decision-making 
processes at the global or national level. It is intended to 
be used holistically—from the beginning of a health deci-
sion-making process to formulating recommendations or 
making a decision at the end of this process.
MeTHods
In addressing these objectives, we followed a three-step 
approach, as illustrated in figure 1.
This paper provides an overview of the research project 
with all of its constituent components. It presents the 
current version of the framework (WHO-INTEGRATE 
framework version 1.0) and its intended use. It also 
reports the detailed methods and findings for steps 1a, 
2a and 3, as well as an overview of the methods and find-
ings for steps 1b and 2b. A full account of the methods 
and findings of step 1b is currently in preparation (Stratil 
et al, forthcoming). An integrated analysis of the views 
of those developing (step 2b) and using WHO guide-
lines (step 2c) with respect to the WHO-INTEGRATE 
framework will also be published separately (Stratil et al, 
forthcoming).
step 1: development of the framework
In step 1a we analysed WHO norms and values and, rooted in 
these norms and values, proposed a structure for the WHO-INTE-
GRATE framework and derived preliminary criteria. A univer-
sally agreed normative theory for health does not exist, 
but most rivalling theories converge on a set of princi-
ples.31 As the use of these principles is less restrictive than 
the choice of one theory over another, we pursued a prin-
ciples-based approach,31 32 and used WHO norms and 
values as the guiding principles for developing a new EtD 
framework. Given the complexities of normative orien-
tation in modern pluralistic and globalised societies, we 
believe that WHO norms and values represent a useful 
foundation: they are rooted in the universally recog-
nised concept of human rights and receive their legit-
imacy from having been agreed on by all 194 Member 
States of the WHO. To identify WHO norms and values 
of relevance to the process of guideline development 
and implementation, we used the WHO Constitution33 
and chapter 5 ‘Incorporating equity, human rights, gender 
and social determinants into guidelines’ of the WHO Hand-
book for Guideline Development22 as a starting point. Given 
the emphasis in these two documents on human rights, 
equity and non-discrimination, social determinants of 
health and the role of health systems, we retrieved and 
analysed relevant related documents,34–40 including 
several public health ethics frameworks.16 18 41–50 We 
Figure 1 Towards a useful and operational WHO-INTEGRATE (INTEGRATe Evidence) framework.
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also reviewed the SDGs51 in view of their likely impact at 
global and national levels and as WHO is mainstreaming 
these throughout the organisation’s work.52–54
From these documents and sources, we derived prin-
ciples and concepts. The structure of the WHO-INTE-
GRATE framework was developed via an iterative process 
among coauthors. We explored the meaning of different 
principles and concepts and assessed overlap and redun-
dancies, making rearrangements to derive preliminary 
criteria. In doing so, we used a structure and wording 
as close as possible to the existing GRADE EtD frame-
work to build on its strengths and to maximise potential 
synergies. On several occasions, we also consulted with 
members of the WHO Guidelines Review Committee as 
well as other WHO staff considered experts on selected 
principles or concepts (see Acknowledgements).
During the development process, we focused on 
substantive criteria or what decisions are based on (eg, 
cost, acceptability) rather than procedural criteria or 
how the decision-making process is conducted (eg, 
composition of guideline panels, participation, transpar-
ency). This is consistent with the approach promoted 
by the WHO Handbook for Guideline Development,22 whose 
overall purpose is to specify procedural rules for an 
objective, transparent and acceptable guideline develop-
ment process. Embedded in these procedural rules, the 
current WHO EtD framework (table 10.1 of the WHO 
Handbook for Guideline Development)22—and, by extension, 
the WHO-INTEGRATE framework presented here—
is concerned with how to facilitate the use of evidence 
in decision-making in a structured and comprehensive 
manner. It is important to note that a distinction between 
structural and procedural aspects is widely practised in 
guideline development and several other health deci-
sion-making processes,5 6 19 55 but is not commonly seen 
in the public health ethics literature.43 44 46 56
In step 1b we refined the preliminary criteria derived from 
WHO and other related documents and supplemented them with 
a comprehensive set of subcriteria; we also developed definitions 
for criteria and example questions relating to each of the subcri-
teria. We conducted an overview of systematic reviews 
of criteria used in decision-making, priority setting and 
resource allocation processes for health to derive a 
comprehensive set of health-relevant criteria (Stratil et 
al, forthcoming). We then compared the preliminary 
criteria developed in step 1a against this comprehensive 
set of criteria and subcriteria. To do so, one author (JMS), 
in a discussion with a second author (EAR), allotted the 
subcriteria obtained from the overview of systematic 
reviews to the preliminary criteria within the WHO-INTE-
GRATE framework. Subcriteria that did not fit were kept 
in a separate category. Any uncertainties were resolved in 
discussion with a third author (RB).
We then prepared definitions for each of the criteria 
using the above-described source documents for health 
norms and values, existing health decision frameworks 
(Stratil et al, forthcoming), and any definitions or 
descriptions provided in the publications included in 
our overview of systematic reviews of criteria (Stratil et 
al, forthcoming). Where appropriate, we also drew on 
additional key documents (eg, Scott et al 57 for the defi-
nition of acceptability, Hultcrantz et al 58 for the concep-
tualisation of quality of evidence, and Maeckelberghe and 
Schröder-Bäck59 for details on the subcriteria for human 
rights and sociocultural acceptability and health equity, equality 
and non-discrimination). Each definition (1) provides an 
overall definition of the criterion, (2) offers details and 
explanations regarding the subcriteria, and (3) gives 
guidance on how the criterion in question influences the 
recommendation.
As we prepared definitions, we also examined the extent 
to which the criteria and subcriteria relate to the inter-
vention itself versus the health system and the broader 
context, in which an intervention is implemented. For 
example, the same label (eg, equity) may be employed 
to describe different underlying concepts, relating to 
process versus outcome (an intervention can either be imple-
mented taking equity principles into account, or it can 
increase or decrease equity in health outcomes) and the 
point in time when these criteria apply (eg, equity before, 
during or after intervention implementation). To enable 
better access to sometimes abstract constructs, we also 
developed example questions for each of the subcriteria, 
drawing on the same set of documents as above.
step 2: assessment of framework value
In step 2a we explored whether the WHO-INTEGRATE frame-
work would be able to accommodate different types of health inter-
ventions and different features of complexity. We assessed to 
what extent the WHO-INTEGRATE framework would be 
able to accommodate features of distinct types of health 
interventions.60 We broadly distinguished between inter-
ventions targeting individuals (eg, diagnosis, treatment 
or preventative measures addressed at individuals), 
interventions targeting populations, and interventions 
targeting the health system or other systems. Popula-
tion-level interventions encompass those concerned with 
whole populations or population groups as defined by 
their age, sex, risk factor profile or other characteris-
tics; they are often implemented in specific settings or 
organisations (eg, school health programmes). System-
level interventions specifically redesign the context in 
which health-relevant behaviours occur; they are often 
implemented through geographical jurisdictions from 
national to local levels (eg, laws and regulations regarding 
the taxation, sale and use of tobacco products). Health 
system interventions represent a specific type of system-
level intervention and often result in complex rearrange-
ments across multiple health system building blocks (eg, 
task shifting as a process of delegating specific health 
service tasks from medical doctors or nurses to less 
specialised health workers). Interventions implemented 
at any of these levels can be conceptualised and analysed 
from a complexity perspective. To do so, we mapped core 
and additional components of complex interventions as 
defined in the iCAT_SR tool61 and sources of complexity 
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in systems reported in another paper in this series28 
against the included criteria.
In step 2b we examined the usefulness and relevance of the 
WHO-INTEGRATE framework and its criteria among those 
developing WHO guidelines. We conducted key informant 
interviews with individuals who had recently participated 
in a WHO guideline development process. In consulta-
tion with the Secretariat of the WHO Guidelines Review 
Committee, we purposively selected three ongoing or 
completed guidelines that had applied the current WHO 
EtD framework,29 62 63 seeking to cover distinct types of 
health interventions and positive as well as more difficult 
experiences with the application of the framework. For 
each guideline, we interviewed the WHO staff coordi-
nating the guideline, the Chair of the guideline develop-
ment group and the methodologist. The interviews were 
semistructured and used a pretested interview guide 
concerned with practical considerations (eg, understand-
ability, operationalisability), as well as an assessment of 
missing and redundant criteria of the WHO-INTEGRATE 
framework. Interviewees were also asked to reflect on 
the implications of the WHO-INTEGRATE framework 
for evidence collection and guideline formulation. 
Interviews were held between June and November 2017 
either face-to-face at the WHO Headquarters in Geneva 
or by telephone (JMS). Interviews were audiotaped and 
transcribed; data were then analysed by two researchers 
(JMS and IBS) using qualitative content analysis.64 We 
employed a combination of deductive (based on the 
guiding research questions) and inductive approaches 
using the software MAXQDA (VERBI Software, Berlin).
step 3: facilitation of framework uptake
We critically examined how to enable use of the WHO-INTE-
GRATE framework as intended, and generated a table linking 
the criteria with suggested methods for primary research, evidence 
synthesis and assessing quality of evidence. The current 
WHO EtD framework is intended to be used right from 
the planning stages of a guideline, to help derive rele-
vant questions and structure the process, but in prac-
tice it is usually used at the end of a guideline process 
to help decide on the recommendations. To determine 
how the new framework could be used more holistically, 
we reflected on the literature reviewed in the context 
of developing the WHO-INTEGRATE framework and 
sought feedback from a large number of experts (see 
Acknowledgements). We specifically sought suggestions 
on how to use the framework during the early stages of 
the guideline development process and in a context-spe-
cific manner.
To make it easier for guideline panels to populate the 
criteria in the framework with evidence, we identified 
types of primary research, evidence synthesis methods and 
methods for assessing evidence quality that could inform 
each criterion. To accomplish this, two researchers (AP 
and EAR) reviewed the research questions and methods 
described or mentioned in the systematic review of health 
decision frameworks and the overview of systematic 
reviews (Stratil et al, forthcoming). We also consulted 
a broad range of experts comprising other authors of 
papers in this series, selected guideline development 
organisations (eg, Guidelines International Network, UK 
National Institute for Health and Care Excellence) and 
researchers with an interest in evaluating complex health 
technologies (see Acknowledgements).
resulTs
developing the preliminary framework
Using the review of the WHO Constitution,33 chapter 5 of 
the WHO Handbook for Guideline Development22 and other 
source documents, we identified six major, partly over-
lapping concepts. Further sorting of these yielded four 
sets of principles and concepts (human rights principles, 
ethical principles, sustainability elements and health 
system goals and building blocks). Figure 2 illustrates 
how we derived preliminary criteria from WHO norms 
and values.
 ► Human rights principles, for the purposes of this 
framework, were primarily derived from interna-
tional human rights law and its interpretation by the 
Committee on Economic, Social and Cultural Rights’ 
General Comment on the Right to the Highest Attain-
able Standard of Health (Art 12).34 These contain the 
interrelated concepts of availability and accessibility 
of public health and healthcare facilities, goods and 
services, which are required to be of appropriate 
quality and acceptable to users. They also include 
the general human rights principles of equity and 
non-discrimination, accountability and participation.
 ► Given the large number of biomedical and public 
health ethics frameworks,44 46 56 in consultation with 
WHO, we structured the ethical principles primarily 
according to the public health ethics framework of 
Childress and colleagues. This framework inter alia 
includes the aspects of producing benefits, avoiding 
harms, maximising the balance between benefits and 
harms, as well as distributive justice and autonomy.41 
Based on analytical tools by the Nuffield Council of 
Bioethics,45 we also added the principle of low intru-
siveness, which is related to privacy and dignity.
 ► Acknowledging the importance of the social deter-
minants of health and the SDGs, we derived sustain-
ability elements to capture the wide range of factors 
that promote conditions in which people can lead 
a healthy life and allow societies and individuals to 
develop and flourish; these sustainability elements 
also reflect the societal impact that interventions can 
have beyond health outcomes. Importantly, good 
health is both a precondition for achieving sustain-
able development and an outcome of sustainable 
development.65
 ► To capture the importance of feasibility of imple-
mentation as well as the impact of interventions on 
the health system, we used the WHO health systems 
framework with its four goals (ie, improved health, 
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responsiveness, social and financial protection, 
improved efficiency) and six building blocks (ie, lead-
ership and governance, financing, medical products, 
vaccines and technologies, information, health work-
force, service delivery infrastructure).19 38–40
Figure 3 presents the WHO-INTEGRATE framework 
with its six criteria: balance of health benefits and harms, 
human rights and sociocultural acceptability, health equity, 
equality and non-discrimination, societal implications, finan-
cial and economic considerations, and feasibility and health 
system considerations. A seventh criterion, quality of evidence, 
represents a metacriterion that applies to each of the 
six substantive criteria. All seven criteria are relevant to 
health decision-making and the formulation of recom-
mendations as part of the guideline development process. 
Each criterion may apply to interventions targeting indi-
viduals, populations or systems, or any combination of 
these levels.
While priority of the problem featured in both the 
health decision frameworks included in our systematic 
review (eg, Alonso-Coello et al 13) and in the overview 
of systematic reviews of criteria (eg, Guindo et al 6), we 
did not include this as a stand-alone substantive crite-
rion for two reasons: First, many of the aspects included, 
for example, political will or public concern, are used 
to inform the decision to develop a guideline (or make 
another health decision) and thus apply before the start 
of the guideline development process. Second, selected 
aspects are captured under the other six substantive 
criteria, for example, burden of disease features under 
balance of health benefits and harms, and large cost of disease 
Figure 3 The WHO-INTEGRATE (INTEGRATe Evidence) 
framework version 1.0.
Figure 2 Sources and concepts for deriving principles-based preliminary criteria rooted in WHO norms and values.
 o
n
 15 July 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000844 on 25 January 2019. Downloaded from 
Rehfuess EA, et al. BMJ Glob Health 2019;4:e000844. doi:10.1136/bmjgh-2018-000844 7
BMJ Global Health
to health system features under financial and economic 
considerations.
defining criteria, subcriteria and example questions
Our overview of systematic reviews yielded more than 
30 systematic reviews that contained several thousand 
criteria and subcriteria currently used in decision-making 
(Stratil et al, forthcoming). Recurrent aspects addressed 
by the subcriteria focused on the health outcomes and 
benefits of the intervention, health benefit for individ-
uals and the benefit for society as a whole, the societal 
importance of the disease, economic considerations, 
quality or uncertainty of evidence, as well as population 
priorities, priorities within the health system and stake-
holders’ interests and pressures. Feasibility criteria were 
concerned with the available budget, the capacities within 
the health system, technological complexity and accepta-
bility of the intervention within society. Some systematic 
reviews were primarily concerned with interventions that 
would benefit vulnerable or marginalised populations 
(eg, children, mothers, people with lower socioeconomic 
status). In many reviews, normative criteria such as ethics, 
justice or fairness were mentioned without clear defini-
tions or contextualisation. This comprehensive list did 
not yield any further criteria beyond the seven presented 
in figure 2. It did, however, provide many subcriteria as 
well as elements used in the development of detailed 
definitions and example questions for each criterion.
suitability of the framework for decisions about complex 
health interventions
An earlier paper in this series28 emphasises the impor-
tance and added value of reviewing evidence from a 
complex systems perspective. In developing the new 
EtD framework, we wanted to ensure that it would be 
fit for purpose when making decisions about complex 
interventions implemented in complex systems. We 
first explored to what extent different features of inter-
vention and system complexity apply to two broad cate-
gories of interventions, that is, individual-level versus 
population-level and system-level interventions (table 1). 
Notably, even population-level and system-level interven-
tions (eg, regulations and programmes to increase access 
to improved sanitation) eventually bring about changes 
in individual behaviour (eg, use and maintenance of 
toilets or latrines). Some criteria apply to a greater extent 
with population-level and system-level interventions 
(eg, societal implications) than individual-level interven-
tions. Some subcriteria may take on a different meaning 
when applied to individual-level versus population-level 
and system-level interventions (eg, autonomy). Broadly 
speaking, most features of complex interventions apply 
to both individual-level and population-level/system-
level interventions but are more salient for the latter. In 
contrast, many features of complex systems only apply to 
population-level and system-level interventions.
The last column of table 1 illustrates that distinct 
features of complexity do not neatly map onto specific 
criteria. Instead, distinct features of complexity usually 
affect multiple, sometimes all, criteria in the WHO-INTE-
GRATE framework. For example, the worked example of 
childhood obesity, introduced in an earlier paper in this 
series,28 discussed adaptivity of the system in response to 
raised taxes on soft drinks (eg, creation of lower-sugar 
alternatives by the soft drinks industry). This adap-
tivity can thus influence the balance of health benefits and 
harms (eg, consumption patterns of soft drinks change 
but in less pronounced ways, thereby dampening the 
expected effect on childhood obesity), and it may even 
have unwanted social consequences by stigmatising 
those unable to afford soft drinks (social impact). Raising 
taxes on only one sugar-sweetened product may lead to 
increasing the sugar content of other sugar-sweetened 
products (impact on economy, broader positive or negative 
health-related impacts) or have implications on agricul-
tural production patterns nationally and internationally 
(impact on economy and environmental impact), illustrating 
the complexity of downstream implications of a ‘simple’ 
intervention. Drawing on the same worked example, 
box 1 illustrates how a simple linear perspective on 
the effect of an intervention will place the emphasis 
on one or a few criteria for decision-making, whereas a 
complexity perspective may take all criteria into account 
when making a recommendation.
usefulness of the framework from the perspective of WHo 
guideline developers
The key informants we interviewed had been involved in 
developing three very different guidelines—the WHO 
recommendations on antenatal care,29 the WHO consol-
idated guideline on sexual and reproductive health and 
rights of women living with HIV,62 and the WHO guide-
line on risk communication (online supplementary table 
S1).63 Each of these guidelines faced different challenges 
in terms of scope, availability of evidence and ability to 
incorporate multiple perspectives. All three had used the 
current WHO EtD framework with varying success. The 
diverse experiences and viewpoints of the key informants 
on the practical application of these criteria in guideline 
development were helpful in refining the framework. 
Further detail on and complete findings from the key 
informant interviews will be reported separately (Stratil 
et al, forthcoming).
Most participants commented positively on the 
WHO-INTEGRATE framework and highlighted the 
value of a criterion assessing societal implications, as 
well as the broader and more detailed specification of 
the criteria human rights and sociocultural acceptability and 
health equity, equality and non-discrimination. Two partici-
pants questioned the added value of the new EtD frame-
work, since any guideline development process led by an 
experienced methodologist would automatically address 
the details covered in the subcriteria. Several participants 
were concerned about the workload that the use of the 
WHO-INTEGRATE framework might add to the guide-
line development process.
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Specific remarks were made in regard to (1) missing 
criteria and subcriteria; (2) the hierarchy and order of 
criteria and subcriteria; (3) overlap and redundancies 
between criteria and subcriteria; (4) the precise wording 
and definitions of criteria; (5) the need for (more) guid-
ance on how to use and interpret criteria and subcriteria; 
(6) the challenges of identifying and synthesising the 
required evidence; (7) resource, time and skill implica-
tions for the guideline development process; as well as 
(8) procedural aspects for using the framework in the 
guideline development process.
In response to these concerns and suggestions, we 
made several modifications, including changing the 
name and definition of several criteria and subcriteria to 
improve clarity and reduce overlap. We also expanded 
the example questions for the subcriteria to improve 
understandability and facilitate the development of 
specific questions for a given guideline. Moreover, we 
added suggestions on how to prioritise among criteria 
and subcriteria in a problem-specific and context-spe-
cific manner. Finally, we emphasised the importance of 
incorporating the voices of those directly affected by P
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box 1 Thinking through the criteria in relation to raised 
taxes on soft drinks and their implications
A simple perspective on raising taxes on soft drinks would 
emphasise the linear impacts of this intervention on consumption of 
sugar-sweetened beverages (intermediate outcome) and different 
measures of childhood obesity (ultimate outcome of interest); with 
this perspective, the criterion balance of health benefits and harms 
would warrant the most attention. A complexity perspective on the 
same intervention would not start off with a preconception about a 
single criterion being most influential but carefully examine all criteria. 
For illustration purposes, this complexity perspective would examine 
acceptability among and likely reactions from different groups of 
stakeholders (eg, children, their parents), and pay specific attention to 
the response from vendors and producers of soft drinks (eg, potential 
sugar reduction in drinks with implications for the prices of these 
drinks), which may dampen the expected effect of the tax intervention, 
in terms of changes in consumption patterns, perceptions of the 
intervention and changes in social norms.
 
This complexity perspective would also encompass potential negative 
impacts on health equity, equality and non-discrimination (eg, 
expected or unexpected changes in consumption patterns across 
different socioeconomic or other population groups), explore positive 
or negative social, environmental or economic impacts (eg, changes 
in social norms in relation to sugar-sweetened beverages or their 
alternatives being more or less desirable among different population 
groups, changes in acceptability of further interventions to reduce 
sugar consumption), adopt a societal perspective in estimating the 
financial and economic impacts of the intervention (eg, including how 
costs and benefits of the raised taxes are distributed among different 
stakeholders and sectors), and pay attention to feasibility and health 
system considerations (eg, implications for human resources involved 
with other ongoing efforts to reduce consumption of sugar-sweetened 
beverages and childhood obesity).
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the recommendations into the guideline development 
process.
Table 2 presents the WHO-INTEGRATE framework 
version 1.0 criteria with abbreviated definitions and lists 
subcriteria. Online supplementary table S2 provides 
detailed definitions of the criteria as well as example 
questions for each of the sub criteria.
Facilitating uptake: using the framework holistically and 
populating the criteria with evidence
The WHO-INTEGRATE framework is intended to 
improve transparency in health decision-making by 
supporting a structured process of reflection and discus-
sion in a problem-specific and context-specific manner. 
To be most effective, this process must begin at the start 
of a guideline or other health decision-making process 
and must take evidence into account. The WHO-INTE-
GRATE framework is not intended as a ‘tick-box exercise’; 
there must be prioritisation of the most relevant criteria 
and subcriteria depending on the questions addressed by 
a given guideline, and the time and resources at disposi-
tion. It would be impossible and probably unnecessary for 
every guideline development or health decision-making 
process to examine all subcriteria. This flexibility can, 
however, lead to misuse, as stakeholders may dispropor-
tionately (eg, academics from high-income countries) 
or unduly (eg, participants with substantial declared or 
undeclared financial or other conflicts of interest) influ-
ence the decision-making process. Safeguards can be put 
in place through explicit procedures, in particular in 
relation to the composition of guideline panels or other 
decision-making groups. The WHO-INTEGRATE frame-
work is also not an algorithm for integrating evidence 
across different criteria: making decisions under uncer-
tainty and agreeing on trade-offs across criteria and 
subcriteria and among (and within) diverse stakeholder 
groups remain a core task for a guideline panel.
All criteria are important and should be reflected on, 
but their relevance varies depending on the type of health 
decision and the decision-making context. In contrast, 
not all subcriteria are always relevant. At the start of a 
guideline or other decision-making process, an appropri-
ately composed guideline panel or other decision-making 
group needs to discuss which of the subcriteria are appli-
cable and useful in relation to the nature and specific 
characteristics of the intervention (see table 1); this 
group will also need to consider the specific information 
needed to populate criteria or subcriteria (see table 3). 
Complexity in the intervention and complexity in the 
system into which this intervention is implemented can 
usually be detected; the critical question is whether it is of 
value to examine this complexity in depth (see box 1 in 
this paper and box 2 in an earlier paper in this series28). 
This prioritisation process should take the views of rele-
vant stakeholder groups into account; which stakeholder 
groups are relevant depends on the nature of the problem 
and the institutional as well as broader physical and social 
context. In principle, these should include those directly 
affected by the intervention (eg, patients, beneficiaries), 
those financing (eg, health insurance providers, minis-
tries of health, other ministries) or implementing the 
intervention (eg, healthcare providers, public health 
professionals, professionals outside of the health sector), 
as well as the general public.
A systematic weakness in many guideline develop-
ment and other health decision-making processes is that 
consumer participation is obviated and guideline panels 
often substitute their own values and views for those of 
patients/beneficiaries. The voices of patients/beneficia-
ries and other relevant stakeholder groups can be incor-
porated through direct participation or representative 
surveys66 as well as qualitative research (see table 3).
The guideline panel will also need to decide how best 
to populate the criteria with evidence and whether a 
formal evidence synthesis or a more pragmatic approach 
is warranted for each. This decision will be influenced by 
the relevance of criteria and subcriteria in relation to a 
specific intervention or decision, and by the likely types 
and quantity of evidence available, as well as time and 
resource constraints. At the end of the process, the guide-
line panel will need to reassess the criteria and relevant 
subcriteria in light of the assembled evidence and make a 
judgement regarding each criterion.
Table 3 suggests relevant types of primary research, 
evidence synthesis or mapping methods, streamlined 
or pragmatic approaches, as well as methods to assess 
the quality of evidence for each of the six substantive 
criteria. We provide a collection of suitable primary 
research and synthesis approaches, but make no firm 
distinction between more or less suitable methods. 
We note that the approach to gathering evidence may 
depend on the criterion: for some criteria a systematic 
review will be most appropriate, while for others a repre-
sentative survey or other single primary study may be 
more suitable. Surprisingly, the majority of the health 
decision frameworks included in our systematic review 
(Stratil et al, forthcoming) did not offer insights for 
operationalising frameworks, for example by specifying 
research questions or suggesting methods for primary 
research or evidence synthesis. The GRADE EtD frame-
work13 67 and the EUnetHTA (EUropean network for 
Health Technology Assessment) core model68 provided 
some methods. We also identified relevant information 
in the following sources: the EVIDEM (Evidence and 
Value: Impact on DEcisionMaking) framework,14 Marck-
mann and colleagues,16 the health systems framework19 
and publications included in our overview of systematic 
reviews of criteria.69 Expert consultation played a critical 
role in identifying methods for inclusion in table 3.
dIsCussIon
Added value of the WHo-InTegrATe framework
The WHO-INTEGRATE framework represents a new 
comprehensive EtD framework that is rooted in WHO 
norms and values. It offers an explicit conceptualisation 
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of each criterion and a rationale for including relevant 
concepts as criteria or subcriteria. The WHO norms and 
values apply across all WHO Member States and settings, 
and the new framework should, in principle, be relevant 
for health decision-making at global, national and subna-
tional levels. It reflects a broad understanding of health 
and its determinants and takes account of complex inter-
ventions and complex systems perspectives. It emphasises 
sustainability and the interconnectedness between health 
and other sectors, inherent in the SDGs. While the frame-
work is conceived for individual-level, population-level 
and system-level interventions, it is likely to be particu-
larly well suited for public health and health system inter-
ventions characterised by complexity and/or approached 
from a complexity perspective. The WHO-INTEGRATE 
framework is intended as a tool to facilitate structured 
reflection and discussions from the beginning of a 
guideline development or other health decision-making 
process. This has ramifications in terms of the need to 
prioritise among criteria and subcriteria and the need to 
collect evidence for each. The framework supports this 
process by offering structured definitions for each crite-
rion and example questions for each subcriterion, and 
by suggesting methods for primary research, evidence 
synthesis and assessing the quality of the evidence.
There are many similarities between the WHO-IN-
TEGRATE framework and the widely used GRADE EtD 
framework. As stated in our methods, we deliberately 
attempted to stay as close as possible to the GRADE 
EtD framework, thus building on established terms 
and concepts (eg, balance of health benefits and harms). In 
contrast, criteria with a strong normative foundation (eg, 
health equity, equality and non-discrimination) were much 
less developed in the GRADE EtD framework; notably, 
the criterion societal implications, which has its roots in the 
recognition of the multisectoral determinants of health, 
is absent from the GRADE EtD framework. There are 
also more fundamental differences. While the GRADE 
EtD framework emphasises the efficacy/effectiveness of 
interventions and their potential harmful impacts, there 
is no inherent weighting of criteria in the WHO-INTE-
GRATE framework: guideline panels must decide in a 
context-specific and problem-specific manner which 
criteria and subcriteria are most relevant. Moreover, in 
contrast to the narrower certainty of evidence concept 
in the GRADE EtD framework, the WHO-INTEGRATE 
framework has deliberately adopted a broad quality of 
evidence concept that applies across all criteria and is 
not linked to a prespecified grading system. For several 
criteria (and/or subcriteria) GRADE70 71 and GRADE 
CERQual (Confidence in the Evidence from Reviews 
of Qualitative Research72) are the most appropriate 
approaches to examining quality of evidence, and 
we would encourage users of the WHO-INTEGRATE 
framework to adopt these. In fact, another paper in this 
series explores how complexity can be considered when 
assessing the certainty of evidence on intervention effec-
tiveness.73 For other criteria (and/or subcriteria), these C
ri
te
ri
a 
an
d
 a
b
b
re
vi
at
ed
 d
efi
ni
ti
o
ns
S
ub
cr
it
er
ia
Im
p
lic
at
io
ns
 f
o
r 
a 
re
co
m
m
en
d
at
io
n
Fe
as
ib
ili
ty
 a
nd
 h
ea
lt
h 
sy
st
em
 c
o
ns
id
er
at
io
ns
Fe
as
ib
ili
ty
 a
nd
 h
ea
lth
 s
ys
te
m
 c
on
si
d
er
at
io
ns
 r
ec
og
ni
se
 t
ha
t 
th
e 
m
os
t 
ap
p
ro
p
ria
te
 a
nd
 fe
as
ib
le
 in
te
rv
en
tio
ns
 m
ay
 v
ar
y 
si
gn
ifi
ca
nt
ly
 a
cr
os
s 
d
iff
er
en
t 
co
nt
ex
ts
, b
ot
h 
ac
ro
ss
 c
ou
nt
rie
s 
an
d
 a
cr
os
s 
ju
ris
d
ic
tio
ns
 w
ith
in
 
co
un
tr
ie
s.
 L
eg
is
la
tio
n 
an
d
 g
ov
er
na
nc
e,
 t
he
 s
tr
uc
tu
re
 o
f t
he
 h
ea
lth
 s
ys
te
m
 
an
d
 e
xi
st
in
g 
p
ro
gr
am
m
es
, a
s 
w
el
l a
s 
hu
m
an
 r
es
ou
rc
es
 a
nd
 in
fr
as
tr
uc
tu
re
, 
sh
ou
ld
 b
e 
ta
ke
n 
in
to
 a
cc
ou
nt
.
 
►
Le
gi
sl
at
io
n.
 
►
Le
ad
er
sh
ip
 a
nd
 g
ov
er
na
nc
e.
 
►
In
te
ra
ct
io
n 
w
ith
 a
nd
 im
p
ac
t 
on
 h
ea
lth
 s
ys
te
m
.
 
►
N
ee
d
 fo
r, 
us
ag
e 
of
 a
nd
 im
p
ac
t 
on
 h
ea
lth
 w
or
kf
or
ce
 a
nd
 
hu
m
an
 r
es
ou
rc
es
.
 
►
N
ee
d
 fo
r, 
us
ag
e 
of
 a
nd
 im
p
ac
t 
on
 in
fr
as
tr
uc
tu
re
.
Th
e 
gr
ea
te
r 
th
e 
fe
as
ib
ili
ty
 o
f a
n 
op
tio
n 
fr
om
 t
he
 
p
er
sp
ec
tiv
e 
of
 a
ll 
or
 m
os
t 
st
ak
eh
ol
d
er
s,
 t
he
 g
re
at
er
 
th
e 
lik
el
ih
oo
d
 o
f a
 g
en
er
al
 r
ec
om
m
en
d
at
io
n 
in
 
fa
vo
ur
 o
f t
he
 in
te
rv
en
tio
n.
 T
he
 m
or
e 
ad
va
nt
ag
eo
us
 
th
e 
im
p
lic
at
io
ns
 fo
r 
th
e 
he
al
th
 s
ys
te
m
 a
s 
a 
w
ho
le
, t
he
 g
re
at
er
 t
he
 li
ke
lih
oo
d
 o
f a
 g
en
er
al
 
re
co
m
m
en
d
at
io
n 
in
 fa
vo
ur
 o
f t
he
 in
te
rv
en
tio
n.
Q
ua
lit
y 
o
f 
ev
id
en
ce
Q
ua
lit
y 
of
 e
vi
d
en
ce
, a
ls
o 
re
fe
rr
ed
 t
o 
as
 c
er
ta
in
ty
 o
f e
vi
d
en
ce
 o
r 
st
re
ng
th
 o
f 
ev
id
en
ce
, r
efl
ec
ts
 t
he
 c
on
fid
en
ce
 t
ha
t 
th
e 
av
ai
la
b
le
 e
vi
d
en
ce
 is
 a
d
eq
ua
te
 
to
 s
up
p
or
t 
a 
re
co
m
m
en
d
at
io
n.
 In
 p
rin
ci
p
le
, q
ua
lit
y 
of
 e
vi
d
en
ce
 c
an
 b
e 
ap
p
lie
d
 a
cr
os
s 
al
l c
rit
er
ia
 in
 t
he
 W
H
O
-I
N
TE
G
R
AT
E
 fr
am
ew
or
k.
 A
s 
a 
la
rg
e 
nu
m
b
er
 o
f c
rit
er
ia
 a
re
 in
te
gr
at
ed
 in
 t
he
 d
ec
is
io
n-
m
ak
in
g 
p
ro
ce
ss
, e
vi
d
en
ce
 
is
 in
te
rp
re
te
d
 in
 t
he
 b
ro
ad
es
t 
se
ns
e 
an
d
 a
llo
w
s 
fo
r 
re
le
va
nt
 c
on
tr
ib
ut
io
ns
 
fr
om
 a
 v
ar
ie
ty
 o
f d
is
ci
p
lin
ar
y 
ap
p
ro
ac
he
s.
 M
or
eo
ve
r, 
d
ec
is
io
n-
m
ak
in
g 
un
d
er
 
un
ce
rt
ai
nt
y 
of
te
n 
in
vo
lv
es
 s
ta
ke
ho
ld
er
 e
xp
er
ie
nc
e 
an
d
 ju
d
ge
m
en
t,
 w
he
n 
st
ro
ng
er
 e
vi
d
en
ce
 is
 u
na
va
ila
b
le
.
–
Th
e 
gr
ea
te
r 
th
e 
q
ua
lit
y 
of
 t
he
 e
vi
d
en
ce
 a
cr
os
s 
d
iff
er
en
t 
cr
ite
ria
 in
 t
he
 W
H
O
-I
N
TE
G
R
AT
E
 
fr
am
ew
or
k,
 t
he
 g
re
at
er
 t
he
 li
ke
lih
oo
d
 o
f a
 g
en
er
al
 
re
co
m
m
en
d
at
io
n.
IN
TE
G
R
AT
E
, I
N
TE
G
R
AT
e 
E
vi
d
en
ce
.
Ta
b
le
 2
 
C
on
tin
ue
d
 
 o
n
 15 July 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000844 on 25 January 2019. Downloaded from 
14 Rehfuess EA, et al. BMJ Glob Health 2019;4:e000844. doi:10.1136/bmjgh-2018-000844
BMJ Global Health
Ta
b
le
 3
 
W
H
O
-I
N
TE
G
R
AT
E
 fr
am
ew
or
k 
ve
rs
io
n 
1.
0:
 c
rit
er
ia
 a
nd
 s
ug
ge
st
ed
 t
yp
es
 o
f p
rim
ar
y 
st
ud
ie
s,
 e
vi
d
en
ce
 s
yn
th
es
is
 m
et
ho
d
s 
an
d
 a
p
p
ro
ac
he
s 
to
 a
ss
es
si
ng
 q
ua
lit
y 
of
 
ev
id
en
ce
C
ri
te
ri
a
Ty
p
es
 o
f 
p
ri
m
ar
y 
st
ud
ie
s*
E
vi
d
en
ce
 s
yn
th
es
is
 o
r 
m
ap
p
in
g
 
m
et
ho
d
s
P
ra
g
m
at
ic
 a
p
p
ro
ac
he
s
A
p
p
ro
ac
he
s 
to
 a
ss
es
si
ng
 q
ua
lit
y 
o
f 
ev
id
en
ce
B
al
an
ce
 o
f 
he
al
th
 b
en
efi
ts
 
an
d
 h
ar
m
s.
 
►
E
ffi
ca
cy
 o
r 
ef
fe
ct
iv
en
es
s 
on
 h
ea
lth
 
of
 in
d
iv
id
ua
ls
/p
op
ul
at
io
ns
: R
C
Ts
, 
p
ra
gm
at
ic
 t
ria
ls
, q
ua
si
-e
xp
er
im
en
ta
l 
st
ud
ie
s,
 c
om
p
ar
at
iv
e 
ob
se
rv
at
io
na
l 
st
ud
ie
s;
 lo
ng
er
 t
er
m
 o
b
se
rv
at
io
na
l 
st
ud
ie
s,
 m
od
el
lin
g 
(e
g,
 t
ra
ns
m
is
si
on
 
m
od
el
lin
g 
fo
r 
in
fe
ct
io
us
 d
is
ea
se
s)
.
 
►
P
at
ie
nt
s’
/b
en
efi
ci
ar
ie
s’
 v
al
ue
s 
in
 r
el
at
io
n 
to
 h
ea
lth
 o
ut
co
m
es
: 
q
ua
lit
at
iv
e 
st
ud
ie
s 
(e
g,
 s
em
is
tr
uc
tu
re
d
 
in
te
rv
ie
w
s,
 fo
cu
s 
gr
ou
p
s)
, c
ro
ss
-
se
ct
io
na
l s
tu
d
ie
s.
 
►
S
af
et
y 
ris
k 
p
ro
fil
e 
of
 in
te
rv
en
tio
n:
 
R
C
Ts
, q
ua
si
-e
xp
er
im
en
ta
l s
tu
d
ie
s,
 
co
m
p
ar
at
iv
e 
ob
se
rv
at
io
na
l s
tu
d
ie
s 
fo
r 
an
tic
ip
at
ed
 h
ar
m
s;
 r
eg
is
tr
y 
st
ud
ie
s,
 lo
ng
er
 t
er
m
 o
b
se
rv
at
io
na
l 
st
ud
ie
s,
 c
as
e 
se
rie
s,
 c
as
e 
re
p
or
ts
 fo
r 
un
an
tic
ip
at
ed
 e
ffe
ct
s.
 
►
B
ro
ad
er
 p
os
iti
ve
 o
r 
ne
ga
tiv
e 
he
al
th
-
re
la
te
d
 im
p
ac
ts
: R
C
Ts
, q
ua
si
-
ex
p
er
im
en
ta
l s
tu
d
ie
s,
 o
b
se
rv
at
io
na
l 
st
ud
ie
s,
 q
ua
lit
at
iv
e 
st
ud
ie
s.
 
►
S
ys
te
m
at
ic
 r
ev
ie
w
s 
of
 e
ffi
ca
cy
/
ef
fe
ct
iv
en
es
s8
3  
fo
r 
an
tic
ip
at
ed
 e
ffe
ct
s.
 
►
Q
ua
lit
at
iv
e 
ev
id
en
ce
 
sy
nt
he
se
s8
4 
85
 a
nd
 m
ix
ed
-m
et
ho
d
 
re
vi
ew
s8
6  
or
 c
ro
ss
-s
ec
tio
na
l s
tu
d
ie
s6
6  
fo
r 
p
at
ie
nt
s’
/b
en
efi
ci
ar
ie
s’
 v
al
ue
s 
in
 
re
la
tio
n 
to
 h
ea
lth
 o
ut
co
m
es
.
 
►
S
co
p
in
g 
re
vi
ew
s8
7 
88
 fo
r 
un
an
tic
ip
at
ed
 
ef
fe
ct
s.
 
►
R
ap
id
 r
ev
ie
w
s 
of
 e
ffi
ca
cy
/
ef
fe
ct
iv
en
es
s.
89
–9
1
 
►
O
ve
rv
ie
w
s 
of
 s
ys
te
m
at
ic
 
re
vi
ew
s.
83
 9
2
 
►
G
R
A
D
E
.7
0 
71
 7
3
C
on
tin
ue
d
 o
n
 15 July 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000844 on 25 January 2019. Downloaded from 
Rehfuess EA, et al. BMJ Glob Health 2019;4:e000844. doi:10.1136/bmjgh-2018-000844 15
BMJ Global Health
C
ri
te
ri
a
Ty
p
es
 o
f 
p
ri
m
ar
y 
st
ud
ie
s*
E
vi
d
en
ce
 s
yn
th
es
is
 o
r 
m
ap
p
in
g
 
m
et
ho
d
s
P
ra
g
m
at
ic
 a
p
p
ro
ac
he
s
A
p
p
ro
ac
he
s 
to
 a
ss
es
si
ng
 q
ua
lit
y 
o
f 
ev
id
en
ce
H
um
an
 
rig
ht
s 
an
d
 
so
ci
oc
ul
tu
ra
l 
ac
ce
p
ta
b
ili
ty
.
 
►
A
cc
or
d
an
ce
 w
ith
 u
ni
ve
rs
al
 h
um
an
 
rig
ht
s 
st
an
d
ar
d
s:
 m
ap
p
in
g 
of
 r
el
ev
an
t 
as
p
ec
ts
, p
ro
 e
t 
co
nt
ra
 a
na
ly
si
s,
93
 
et
hi
ca
l a
na
ly
si
s 
(e
g,
 c
as
ui
st
ry
, 
co
he
re
nc
e 
an
al
ys
is
, w
id
e 
re
fle
ct
iv
e 
eq
ui
lib
riu
m
),9
4  
p
ow
er
 a
na
ly
se
s,
 
hu
m
an
 r
ig
ht
s 
im
p
ac
t 
as
se
ss
m
en
t.
95
 
►
S
oc
io
cu
ltu
ra
l a
cc
ep
ta
b
ili
ty
 o
f 
in
te
rv
en
tio
n,
 im
p
ac
t 
on
 a
ut
on
om
y 
of
 c
on
ce
rn
ed
 s
ta
ke
ho
ld
er
s,
 
in
tr
us
iv
en
es
s 
of
 in
te
rv
en
tio
n:
 m
ap
p
in
g 
of
 r
el
ev
an
t 
as
p
ec
ts
, p
ro
 e
t 
co
nt
ra
 
an
al
ys
is
,9
3  
d
is
co
ur
se
 a
na
ly
si
s,
 
q
ua
lit
at
iv
e 
st
ud
ie
s 
(id
ea
lly
 lo
ng
itu
d
in
al
 
to
 e
xa
m
in
e 
ch
an
ge
s 
ov
er
 t
im
e)
, 
d
is
cr
et
e 
ch
oi
ce
 e
xp
er
im
en
ts
, c
ro
ss
-
se
ct
io
na
l s
tu
d
ie
s,
66
 lo
ng
itu
d
in
al
 
q
ua
nt
ita
tiv
e 
st
ud
ie
s 
(to
 e
xa
m
in
e 
ch
an
ge
s 
ov
er
 t
im
e)
, m
ix
ed
-m
et
ho
d
 
st
ud
ie
s.
 
►
E
th
ic
s 
sy
nt
he
se
s9
6 
97
 fo
r 
ac
co
rd
an
ce
 
w
ith
 u
ni
ve
rs
al
 h
um
an
 r
ig
ht
s 
st
an
d
ar
d
s.
 
►
Q
ua
lit
at
iv
e 
ev
id
en
ce
 s
yn
th
es
es
84
 8
5 
98
 
an
d
 m
ix
ed
-m
et
ho
d
 r
ev
ie
w
s8
6  
fo
r 
so
ci
oc
ul
tu
ra
l a
cc
ep
ta
b
ili
ty
 a
nd
 im
p
ac
t 
on
 a
ut
on
om
y 
of
 c
on
ce
rn
ed
 
st
ak
eh
ol
d
er
s 
an
d
 in
tr
us
iv
en
es
s 
of
 
in
te
rv
en
tio
ns
.
 
►
P
ur
p
os
iv
el
y 
se
le
ct
ed
 s
tu
d
ie
s 
fr
om
 d
iff
er
en
t 
co
nt
ex
ts
 (t
o 
ill
us
tr
at
e 
b
ro
ad
 s
p
ec
tr
um
 o
f 
is
su
es
).
 
►
G
R
A
D
E
 C
E
R
Q
ua
l7
2 
99
 (w
he
re
 
ap
p
lic
ab
le
).
 
►
Q
-S
E
A
 fo
r 
et
hi
cs
 a
na
ly
se
s.
57
S
oc
ie
ta
l 
im
p
lic
at
io
ns
.
 
►
S
oc
ia
l i
m
p
ac
ts
: R
C
Ts
, q
ua
si
-
ex
p
er
im
en
ta
l s
tu
d
ie
s,
 c
om
p
ar
at
iv
e 
ob
se
rv
at
io
na
l s
tu
d
ie
s,
 lo
ng
itu
d
in
al
 
im
p
le
m
en
ta
tio
n 
st
ud
ie
s,
 q
ua
lit
at
iv
e 
st
ud
ie
s,
 c
as
e 
st
ud
ie
s,
 p
ow
er
 
an
al
ys
es
.
 
►
E
nv
iro
nm
en
ta
l i
m
p
ac
ts
: R
C
Ts
, q
ua
si
-
ex
p
er
im
en
ta
l s
tu
d
ie
s,
 c
om
p
ar
at
iv
e 
ob
se
rv
at
io
na
l s
tu
d
ie
s,
 lo
ng
itu
d
in
al
 
im
p
le
m
en
ta
tio
n 
st
ud
ie
s,
 q
ua
lit
at
iv
e 
st
ud
ie
s,
 c
as
e 
st
ud
ie
s,
 e
nv
iro
nm
en
ta
l 
im
p
ac
t 
as
se
ss
m
en
ts
, m
od
el
lin
g 
st
ud
ie
s.
 
►
C
om
b
in
ed
 s
oc
ia
l, 
en
vi
ro
nm
en
ta
l a
nd
 
ec
on
om
ic
 im
p
ac
ts
: h
ea
lth
 im
p
ac
t 
as
se
ss
m
en
ts
, m
od
el
lin
g 
st
ud
ie
s 
(e
g,
 
d
ec
is
io
n-
an
al
yt
ic
al
 m
od
el
lin
g)
.
 
►
S
ys
te
m
at
ic
 r
ev
ie
w
s 
of
 e
ffe
ct
iv
en
es
s.
83
 
►
Q
ua
lit
at
iv
e 
ev
id
en
ce
 s
yn
th
es
es
.1
1 
84
 8
5
 
►
M
ix
ed
-m
et
ho
d
 r
ev
ie
w
s.
86
 
►
H
ea
lth
 t
ec
hn
ol
og
y 
as
se
ss
m
en
ts
.6
8
 
►
P
ur
p
os
iv
el
y 
se
le
ct
ed
 s
tu
d
ie
s 
fr
om
 d
iff
er
en
t 
co
nt
ex
ts
 (t
o 
ill
us
tr
at
e 
b
ro
ad
 s
p
ec
tr
um
 o
f 
is
su
es
).
 
►
N
o 
st
an
d
ar
d
is
ed
 a
p
p
ro
ac
h.
 
►
G
R
A
D
E
70
 7
1  
(w
he
re
 a
p
p
lic
ab
le
).
Ta
b
le
 3
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 15 July 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000844 on 25 January 2019. Downloaded from 
16 Rehfuess EA, et al. BMJ Glob Health 2019;4:e000844. doi:10.1136/bmjgh-2018-000844
BMJ Global Health
C
ri
te
ri
a
Ty
p
es
 o
f 
p
ri
m
ar
y 
st
ud
ie
s*
E
vi
d
en
ce
 s
yn
th
es
is
 o
r 
m
ap
p
in
g
 
m
et
ho
d
s
P
ra
g
m
at
ic
 a
p
p
ro
ac
he
s
A
p
p
ro
ac
he
s 
to
 a
ss
es
si
ng
 q
ua
lit
y 
o
f 
ev
id
en
ce
H
ea
lth
 e
q
ui
ty
, 
eq
ua
lit
y 
an
d
 n
on
-
d
is
cr
im
in
at
io
n.
 
►
Im
p
ac
t 
on
 h
ea
lth
 e
q
ua
lit
y 
an
d
/
or
 h
ea
lth
 e
q
ui
ty
, d
is
tr
ib
ut
io
n 
of
 
b
en
efi
ts
 a
nd
 h
ar
m
s 
of
 in
te
rv
en
tio
n:
 
hu
m
an
 r
ig
ht
s 
im
p
ac
t 
as
se
ss
m
en
t,
95
 
d
is
ag
gr
eg
at
ed
 R
C
Ts
, q
ua
si
-
ex
p
er
im
en
ta
l o
r 
co
m
p
ar
at
iv
e 
ob
se
rv
at
io
na
l s
tu
d
ie
s,
 R
C
Ts
 a
nd
 
q
ua
si
-e
xp
er
im
en
ta
l o
r 
co
m
p
ar
at
iv
e 
ob
se
rv
at
io
na
l s
tu
d
ie
s 
co
nd
uc
te
d
 
in
 d
is
ad
va
nt
ag
ed
 g
ro
up
s,
10
0  
p
ow
er
 
an
al
ys
es
, G
IS
-b
as
ed
 s
tu
d
ie
s,
 
q
ua
lit
at
iv
e 
st
ud
ie
s,
 e
th
ic
al
 a
na
ly
si
s.
 
►
A
ffo
rd
ab
ili
ty
 o
f i
nt
er
ve
nt
io
n:
 c
ro
ss
-
se
ct
io
na
l o
r 
lo
ng
itu
d
in
al
 o
b
se
rv
at
io
na
l 
st
ud
ie
s,
 d
is
cr
et
e 
ch
oi
ce
 e
xp
er
im
en
ts
, 
q
ua
lit
at
iv
e 
st
ud
ie
s,
 c
at
as
tr
op
hi
c 
he
al
th
 e
xp
en
d
itu
re
 s
tu
d
ie
s.
 
►
A
cc
es
si
b
ili
ty
 o
f i
nt
er
ve
nt
io
n:
 h
ea
lth
 
sy
st
em
 b
ar
rie
r 
st
ud
ie
s,
 c
ro
ss
-
se
ct
io
na
l o
r 
lo
ng
itu
d
in
al
 o
b
se
rv
at
io
na
l 
st
ud
ie
s,
 d
is
cr
et
e 
ch
oi
ce
 e
xp
er
im
en
ts
, 
q
ua
lit
at
iv
e 
st
ud
ie
s,
 e
th
ic
al
 a
na
ly
si
s,
 
G
IS
-b
as
ed
 s
tu
d
ie
s.
 
►
S
ev
er
ity
 a
nd
/o
r 
ra
rit
y 
of
 t
he
 c
on
d
iti
on
: 
he
al
th
 s
ta
te
 v
al
ua
tio
ns
, c
ro
ss
-
se
ct
io
na
l s
tu
d
ie
s 
fo
r 
se
ve
rit
y 
of
 
co
nd
iti
on
; o
b
se
rv
at
io
na
l s
tu
d
ie
s 
fo
r 
fr
eq
ue
nc
y 
(in
ci
d
en
ce
, p
re
va
le
nc
e)
 o
f 
co
nd
iti
on
.
 
►
La
ck
 o
f a
 s
ui
ta
b
le
 a
lte
rn
at
iv
e:
 
si
tu
at
io
n 
an
al
ys
is
 o
f i
nt
er
ve
nt
io
n 
op
tio
ns
; q
ua
nt
ita
tiv
e 
or
 q
ua
lit
at
iv
e 
st
ud
ie
s 
of
 a
d
ve
rs
e 
ef
fe
ct
s 
of
 e
xi
st
in
g 
op
tio
ns
.
 
►
Q
ua
nt
ita
tiv
e 
sy
st
em
at
ic
 r
ev
ie
w
s8
3  
us
in
g 
P
R
O
G
R
E
S
S
10
1  
or
 P
R
O
G
R
E
S
S
 
P
LU
S
,1
02
 w
he
re
 p
os
si
b
le
 u
si
ng
 
p
re
sp
ec
ifi
ed
 s
ub
gr
ou
p
 a
na
ly
se
s.
 
►
Q
ua
nt
ita
tiv
e 
sy
st
em
at
ic
 r
ev
ie
w
s 
ta
rg
et
in
g 
d
is
ad
va
nt
ag
ed
 g
ro
up
s.
 
►
E
q
ui
ty
 w
ei
gh
ts
 a
nd
 s
oc
ia
l w
el
fa
re
 
fu
nc
tio
ns
 in
 e
co
no
m
ic
 a
na
ly
se
s 
(s
ee
 F
in
an
ci
al
 a
nd
 e
co
no
m
ic
 
co
ns
id
er
at
io
ns
).
 
►
Q
ua
lit
at
iv
e 
ev
id
en
ce
 s
yn
th
es
es
11
 8
4 
85
 
an
d
 m
ix
ed
-m
et
ho
d
 r
ev
ie
w
s.
86
 
►
E
th
ic
s 
sy
nt
he
se
s.
96
 9
7
 
►
P
ur
p
os
iv
el
y 
se
le
ct
ed
 s
tu
d
ie
s 
fr
om
 d
iff
er
en
t 
co
nt
ex
ts
 (t
o 
ill
us
tr
at
e 
b
ro
ad
 s
p
ec
tr
um
 o
f 
is
su
es
).
 
►
S
co
p
in
g 
re
vi
ew
s.
87
 8
8
 
►
O
ve
rv
ie
w
s 
of
 s
ys
te
m
at
ic
 
re
vi
ew
s.
83
 9
2
 
►
N
o 
st
an
d
ar
d
is
ed
 a
p
p
ro
ac
h.
 
►
G
R
A
D
E
70
 7
1  
fo
r 
su
b
gr
ou
p
 
an
al
ys
es
 (w
he
re
 a
p
p
lic
ab
le
).
 
►
R
el
ev
an
t 
co
ns
id
er
at
io
ns
, s
uc
h 
as
 in
cl
ud
in
g 
he
al
th
 e
q
ui
ty
 a
s 
an
 
ou
tc
om
e,
 in
 W
el
ch
 e
t 
al
.1
03
Ta
b
le
 3
 
C
on
tin
ue
d
 
C
on
tin
ue
d
 o
n
 15 July 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000844 on 25 January 2019. Downloaded from 
Rehfuess EA, et al. BMJ Glob Health 2019;4:e000844. doi:10.1136/bmjgh-2018-000844 17
BMJ Global Health
C
ri
te
ri
a
Ty
p
es
 o
f 
p
ri
m
ar
y 
st
ud
ie
s*
E
vi
d
en
ce
 s
yn
th
es
is
 o
r 
m
ap
p
in
g
 
m
et
ho
d
s
P
ra
g
m
at
ic
 a
p
p
ro
ac
he
s
A
p
p
ro
ac
he
s 
to
 a
ss
es
si
ng
 q
ua
lit
y 
o
f 
ev
id
en
ce
Fi
na
nc
ia
l a
nd
 
ec
on
om
ic
 
co
ns
id
er
at
io
ns
.
 
►
Fi
na
nc
ia
l i
m
p
ac
t:
 p
ric
es
 a
nd
 p
ric
e 
ju
st
ifi
ca
tio
ns
 fo
r 
un
it 
co
st
s 
p
er
 
b
en
efi
ci
ar
y/
p
op
ul
at
io
n 
ac
co
rd
in
g 
to
 
re
le
va
nt
 p
er
sp
ec
tiv
es
, b
ud
ge
t 
im
p
ac
t 
an
al
ys
is
.1
04
 
►
Im
p
ac
t 
on
 e
co
no
m
y:
 e
co
no
m
ic
 
b
ur
d
en
 o
f d
is
ea
se
 s
tu
d
ie
s,
10
5  
q
ua
si
-
ex
p
er
im
en
ta
l s
tu
d
ie
s,
 c
om
p
ar
at
iv
e 
ob
se
rv
at
io
na
l s
tu
d
ie
s,
 lo
ng
itu
d
in
al
 
im
p
le
m
en
ta
tio
n 
st
ud
ie
s,
 q
ua
lit
at
iv
e 
st
ud
ie
s,
 c
as
e 
st
ud
ie
s,
 m
od
el
lin
g 
st
ud
ie
s.
 
►
R
at
io
 o
f c
os
ts
 a
nd
 b
en
efi
ts
: e
co
no
m
ic
 
an
al
ys
es
 a
s 
a 
co
m
p
ar
at
iv
e 
an
al
ys
is
 o
f 
al
te
rn
at
iv
e 
co
ur
se
s 
of
 a
ct
io
n 
in
 t
er
m
s 
of
 t
he
ir 
co
st
s 
an
d
 c
on
se
q
ue
nc
es
 (e
g,
 
co
st
-m
in
im
is
at
io
n 
an
al
ys
is
, c
os
t-
ef
fe
ct
iv
en
es
s 
an
al
ys
is
, c
os
t-
ut
ili
ty
 
an
al
ys
is
, c
os
t-
b
en
efi
t 
an
al
ys
is
).
 
►
C
om
p
re
he
ns
iv
e 
or
 r
ep
re
se
nt
at
iv
e 
co
st
 o
r 
b
ud
ge
t 
im
p
ac
t 
d
at
a 
at
 t
he
 
ap
p
ro
p
ria
te
 le
ve
l (
gl
ob
al
, r
eg
io
na
l, 
na
tio
na
l, 
su
b
na
tio
na
l).
 
►
E
co
no
m
ic
 b
ur
d
en
 o
f d
is
ea
se
 s
tu
d
ie
s 
un
d
er
ta
ke
n 
at
 t
he
 a
p
p
ro
p
ria
te
 
le
ve
l (
gl
ob
al
, r
eg
io
na
l, 
na
tio
na
l, 
su
b
na
tio
na
l).
 
►
E
co
no
m
ic
 a
na
ly
se
s 
un
d
er
ta
ke
n 
at
 t
he
 
ap
p
ro
p
ria
te
 le
ve
l1
06
 1
07
 o
r 
ec
on
om
ic
 
an
al
ys
is
 r
ev
ie
w
s.
10
8–
11
1
 
►
C
os
t 
or
 b
ud
ge
t 
im
p
ac
t 
d
at
a 
fo
r 
p
ur
p
os
iv
el
y 
se
le
ct
ed
 
co
nt
ex
ts
.
 
►
E
co
no
m
ic
 a
na
ly
se
s 
un
d
er
ta
ke
n 
fo
r 
se
le
ct
ed
 
co
nt
ex
ts
.
 
►
N
o 
st
an
d
ar
d
is
ed
 a
p
p
ro
ac
h.
 
►
R
el
ev
an
t 
co
ns
id
er
at
io
ns
 in
 
D
ru
m
m
on
d
 e
t 
al
10
6  
(c
ha
p
te
r 
3 
an
d
 b
ox
 3
.1
) a
nd
 B
ru
ne
tt
i e
t 
al
.1
12
Fe
as
ib
ili
ty
 a
nd
 
he
al
th
 s
ys
te
m
 
co
ns
id
er
at
io
ns
.
 
►
Le
gi
sl
at
io
n,
 le
ad
er
sh
ip
 a
nd
 
go
ve
rn
an
ce
, i
nt
er
ac
tio
n 
w
ith
 a
nd
 
im
p
ac
t 
on
 h
ea
lth
 s
ys
te
m
, n
ee
d
 
fo
r, 
us
ag
e 
of
 a
nd
 im
p
ac
t 
on
 h
ea
lth
 
w
or
kf
or
ce
, h
um
an
 r
es
ou
rc
es
 a
nd
 
in
fr
as
tr
uc
tu
re
: h
ea
lth
 s
ys
te
m
s 
re
se
ar
ch
,1
13
 in
cl
ud
in
g 
m
ap
p
in
g 
of
 
re
le
va
nt
 a
sp
ec
ts
, s
itu
at
io
n 
an
al
ys
is
, 
cr
os
s-
se
ct
io
na
l s
tu
d
ie
s,
 q
ua
lit
at
iv
e 
st
ud
ie
s,
 c
as
e 
st
ud
ie
s.
 
►
Q
ua
lit
at
iv
e 
ev
id
en
ce
 s
yn
th
es
es
,1
1 
84
 8
5  
m
ix
ed
-m
et
ho
d
 r
ev
ie
w
s.
86
 
►
Fo
rm
al
 c
on
su
lta
tio
n 
of
 
co
nt
en
t 
ex
p
er
ts
.
 
►
N
o 
st
an
d
ar
d
is
ed
 a
p
p
ro
ac
h.
 
►
G
R
A
D
E
 C
E
R
Q
ua
l7
2  
(w
he
re
 
ap
p
lic
ab
le
).
*T
hi
s 
ta
b
le
 o
ffe
rs
 a
 c
ol
le
ct
io
n 
of
 s
ui
ta
b
le
 m
et
ho
d
s 
ra
th
er
 t
ha
n 
gu
id
an
ce
 o
n 
th
e 
m
os
t 
ap
p
ro
p
ria
te
 m
et
ho
d
, w
hi
ch
 d
ep
en
d
s 
on
 t
he
 s
p
ec
ifi
c 
re
se
ar
ch
 q
ue
st
io
n.
 W
he
re
 a
p
p
ro
p
ria
te
, t
he
 o
rd
er
 in
 
w
hi
ch
 t
he
 m
et
ho
d
s 
ar
e 
p
re
se
nt
ed
 im
p
lie
s 
a 
hi
er
ar
ch
y 
of
 e
vi
d
en
ce
 (e
g,
 R
C
Ts
 a
re
 m
or
e 
su
ite
d
 t
o 
as
se
ss
in
g 
q
ue
st
io
ns
 o
f e
ffi
ca
cy
 t
ha
n 
m
od
el
lin
g)
.
G
IS
, g
eo
gr
ap
hi
ca
l i
nf
or
m
at
io
n 
sy
st
em
; G
R
A
D
E
, G
ra
d
in
g 
of
 R
ec
om
m
en
d
at
io
ns
 A
ss
es
sm
en
t,
 D
ev
el
op
m
en
t 
an
d
 E
va
lu
at
io
n;
 G
R
A
D
E
 C
E
R
Q
ua
l, 
C
on
fid
en
ce
 in
 t
he
 E
vi
d
en
ce
 fr
om
 R
ev
ie
w
s 
of
 
Q
ua
lit
at
iv
e 
R
es
ea
rc
h;
 H
TA
, h
ea
lth
 t
ec
hn
ol
og
y 
as
se
ss
m
en
t;
 IN
TE
G
R
AT
E
, I
N
TE
G
R
AT
e 
E
vi
d
en
ce
; Q
-S
E
A
, Q
ua
lit
y 
S
ta
nd
ar
d
s 
fo
r 
E
th
ic
s 
A
na
ly
se
s 
in
 H
TA
; R
C
T,
 r
an
d
om
is
ed
 c
on
tr
ol
le
d
 t
ria
l.
Ta
b
le
 3
 
C
on
tin
ue
d
 
 o
n
 15 July 2019 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2018-000844 on 25 January 2019. Downloaded from 
18 Rehfuess EA, et al. BMJ Glob Health 2019;4:e000844. doi:10.1136/bmjgh-2018-000844
BMJ Global Health
existing tools are not well suited, and we hope that more 
appropriate approaches will become available—whether 
through further developments within the GRADE 
Working Group or independent efforts.
The GRADE EtD framework allows for tailoring of 
criteria, for example by considering a detailed judge-
ment as a stand-alone criterion or by removing a crite-
rion from the GRADE EtD framework and considering 
it prior to the start of the decision-making process13; in 
fact, refinement of the GRADE EtD framework continues 
and has already resulted in suggestions towards more 
detailed specifications of selected criteria.74 Similarly, 
we expect various developments towards a version 2.0 of 
the WHO-INTEGRATE framework (see below). We thus 
envisage specific innovations to be adopted across these 
evolving frameworks and, potentially, convergence over 
time.
strengths and limitations of the development process
In developing the WHO-INTEGRATE framework, we 
combined a principles-based approach with an overview 
of systematic reviews of decision criteria and thus ensured 
a solid, comprehensive normative foundation. We were 
explicit and transparent as to how criteria (see figure 1) 
and subcriteria (Stratil et al, forthcoming) were derived. 
While there is some conceptual overlap at the level of 
the criteria (eg, societal implications and financial and 
economic considerations), there are no significant redun-
dancies among the subcriteria (Stratil et al, forthcoming). 
Cross-linkages among the criteria are emphasised in the 
definitions and example questions.
Solely adapting the substantive criteria may be insuffi-
cient to overcome limitations in guideline development 
or other decision-making processes.22 The WHO-IN-
TEGRATE framework is concerned with substantive 
criteria; it does not comprise procedural criteria but is 
intended to be embedded in a clearly specified health 
decision-making process as described, for example, in 
the WHO Handbook for Guideline Development.22 We recog-
nise that transparent and inclusive procedures are essen-
tial to achieve legitimate health decisions and to resolve 
reasonable disagreement based on competing criteria 
and the various individual, social, cultural and political 
values affecting their interpretation and the explicit or 
implicit weight assigned to them. In this context legiti-
macy refers to the reasonableness, or acceptability, of 
decisions as perceived by the population.75 76 Compro-
mised legitimacy may hinder the effective implemen-
tation of guidelines or other health-relevant decisions. 
Transparent and inclusive procedures require, among 
other considerations, the involvement of relevant stake-
holders in the decision-making process, the public 
announcement of forthcoming decisions including their 
underlying argumentation, and the instalment of mecha-
nisms for appeal.75 76 This is relevant for the development 
of WHO guidelines at the global level, as well as their 
adaptation at the national or subnational levels, where 
a wide array of stakeholders with diverse sets of values 
should be involved.77 78 In our overview of systematic 
reviews, we distilled procedural criteria (Stratil et al, forth-
coming) and suggest that these be reviewed separately 
to inform guideline development and other health deci-
sion processes.18 41 42 45 75 76 79 We also refer to evidence-in-
formed deliberative processes, which explicitly integrate 
the use of substantive criteria with procedural criteria to 
set priorities at national and subnational levels.80–82
The WHO-INTEGRATE framework is a highly inter-
disciplinary framework: each criterion, especially those 
criteria that are less developed in current EtD frame-
works (eg, human rights and sociocultural acceptability) or 
absent from the literature (eg, societal implications), merits 
research to unpack them and, where applicable, provide 
a more detailed normative justification. We anticipate 
constructive input from and exchange with relevant 
disciplines, in particular public health ethics but also 
sociology, environmental sciences, economics and many 
others. Future collaborative research is expected to lead 
to a WHO-INTEGRATE framework version 2.0. This may 
advance the criteria and subcriteria and their normative 
foundations, as well as methodological approaches to 
populate these criteria with evidence.
To examine the value of the WHO-INTEGRATE 
framework to potential users, we conducted empirical 
qualitative research. Insights from interviews with key 
informants in relation to their recent experiences with 
developing WHO guidelines led to several refinements 
in the wording of the criteria and subcriteria and high-
lighted the importance of providing example questions 
as well as suggested methods. We expect that the second 
empirical qualitative research component, focus group 
discussions in Nepal, Uganda, Germany and Brazil, will 
yield additional insights from different perspectives and 
possibly further modifications to the framework. An 
integrated analysis of the views of WHO guideline devel-
opers and users will be published separately (Stratil et al, 
forthcoming).
Several of our key informants expressed concern about 
the potential workload resulting from collecting evidence 
for each of the criteria and, in particular, for the many 
subcriteria in the WHO-INTEGRATE framework. Both 
the process of prioritisation and the process of collecting 
evidence—through high-quality evidence synthesis or 
more pragmatic approaches—need to be tested in prac-
tice. We anticipate sharing worked examples and devel-
oping additional guidance on how to implement the 
framework in practice.
ConClusIons
The WHO-INTEGRATE framework represents a compre-
hensive EtD framework rooted in WHO norms and values 
that is, in principle, suitable for individual-level, popula-
tion-level and system-level health interventions that may 
or may not be characterised by complexity. It offers struc-
tured definitions for each of the six substantive criteria 
as well as the meta-criterion quality of evidence; example 
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questions and suggested methods are provided to facili-
tate uptake. Importantly, this framework is intended to 
be used from the beginning and throughout a guideline 
or other health decision-making process, whether this 
process takes place at the global, national or subnational 
level. In working towards version 2.0, we welcome learning 
from the experiences of those applying the framework, 
as well as from researchers in disciplines concerned with 
the included criteria or subcriteria.
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